// App-Quantinova.ai

2602 : A Novel Beneficial Role for Macitentan in Patients at High Thrombosis Risk: Attenuation of Platelet-Mediated Derangements of Blood Coagulation in Eisenmenger Syndrome

Researchers

Presenter

  • Barry Kevane

Principal Investigators

  • Seamus Allen

  • Kevin Walsh

  • Fionnuala Ni Ainle

  • Karl Egan

  • Patricia Maguire

  • Damien Kenny

  • Susan Crawford

  • Aine Lennon

  • Rhona Savage

  • Esther Doran

  • Elaine Neary

Medical Centers

  • Dept of Neonatology, Rotunda Hospital, Dublin, Ireland

  • Department Medical Oncology Mater Misericordiae University Hospital, Dublin, Ireland

  • UCD School of Biomolecular and Biomedical Science, University College Dublin, Ireland

  • School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

  • Dept of Neonatology, Rotunda Hospital, Dublin, Ireland

  • Department Medical Oncology Mater Misericordiae University Hospital, Dublin, Ireland

  • UCD Conway Institute, SPHERE Research Group, Dublin, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Eisenmenger syndrome

  • Venous thrombosis

Biomarkers

  • Adenomatous Polyposis Coli

  • Catalase

Drug/Treatment

  • macitentan

  • Protein C

  • Evithrom

  • Trypsin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved